Guangzhou Evidence-Based Pharmaceutical Technology Co., Ltd. is a high-tech enterprise established in 2016, specializing in clinical trial operations for pharmaceuticals and full-industry-chain R&D services for traditional Chinese medicine, with core businesses including CRO services, transformation of hospital preparations, regulatory registration, medical services, cultivation of major TCM varieties, and SMO services.
Phase I–IV clinical trials, clinical operations for medical devices, quality control, clinical data management, R&D site inspection support.
A database of over 2,000 medical institution preparations;
Expert review institutions for the Lingnan Famous Prescriptions.
Registration of Hong Kong and Macao proprietary Chinese medicines in the Greater Bay Area;
Registration of proprietary Chinese medicines in Hong Kong and Macao;
Prescription-to-OTC switch registration;
Import drug registration.
Medical services, R&D consulting, Industry standard setting,
Data management and statistical analysis, Human experience research/real-world study.
Product top-level design, Construction of evidence-based evidence systems,
New indication expansion, Academic promotion and brand building.
Initiation stage: site feasibility survey, project initiation support for ethics committee and human genetic resources administration submission and filing, contract negotiation and site initiation support; enrollment and follow-up stage: subject screening and recruitment, trial data entry and review, subject management, site management and maintenance, adverse event and serious adverse event reporting; close-out stage: assistance in query resolution, site close-out, on-site inspection support.
